VTV offers safety and $169B in assets, yet SEIV’s active model delivers better growth and a lower 11.4x P/E. Read more on VTV ...

Jade Biosciences is a pre-revenue biotech focused on JADE101 for IgA nephropathy, offering potential. Read why I rate JBIO ...

DYNF portfolio currently has a tilt towards growth, GARP, and quality stocks outperforming the current market. Find out why ...

Strait of Hormuz shipping halts as Iran tightens control, pushing oil prices higher and risking a global energy shock before the ceasefire ends—get ...

PIMCO PTY fund: 11.7% yield at a 4.83% premium to NAV. Learn coverage, leverage, and high-yield risks—plus why a buy makes ...

U.S. stocks hit record highs as the Strait of Hormuz reopening sank oil and boosted risk-on sentiment. Check out the real ...

Ormat Technologies is uniquely positioned to capitalize on surging AI and data center energy demand. Read more on ORA stock ...

The S&P 500 experienced its fastest positive momentum reversal in over five years, driven by geopolitical events and a sharp ...

MSC Income Fund is close to the sector average P/NAV, but almost all key fundamental parameters are way above sector averages ...

The Trade Desk has endured its steepest selloff in years, driven by worrisome competitive threats and fears. Check out why ...

MPLX's strategic divestitures and fee-based contracts position it for enhanced profitability as new projects come online. See ...

Dollar-commodity correlation remains negative 89% of the time on a one-year rolling basis. Currency movements can directly ...